Performance of Disease Risk Score Matching in Nested Case-Control Studies: A Simulation Study
Authors:
Open Access
- 18 April 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 183 (10) , 949-957
Abstract
In a case-control study, matching on a disease risk score (DRS), which includes many confounders, should theoretically result in greater precision than matching on only a few confounders; however, this has not been investigated. We simulated 1,000 hypothetical cohorts with a binary exposure, a time-to-event outcome, and 13 covariates. Each cohort comprised 2 subcohorts of 10,000 patients each: a historical subcohort and a concurrent subcohort. DRS were estimated in the historical subcohorts and applied to the concurrent subcohorts. Nested case-control studies were conducted in the concurrent subcohorts using incidence density sampling with 2 strategies—matching on age and sex, with adjustment for additional confounders, and matching on DRS—followed by conditional logistic regression for 9 outcome-exposure incidence scenarios. In all scenarios, DRS matching yielded lower average standard errors and mean squared errors than did matching on age and sex. In 6 scenarios, DRS matching also resulted in greater empirical power. DRS matching resulted in less relative bias than did matching on age and sex at lower outcome incidences but more relative bias at higher incidences. Post-hoc analysis revealed that the effect of DRS model misspecification might be more pronounced at higher outcome incidences, resulting in higher relative bias. These results suggest that DRS matching might increase the statistical efficiency of case-control studies, particularly when the outcome is rare.Keywords
This publication has 18 references indexed in Scilit:
- Disease risk score as a confounder summary method: systematic review and recommendationsPharmacoepidemiology and Drug Safety, 2012
- Role of disease risk scores in comparative effectiveness research with emerging therapiesPharmacoepidemiology and Drug Safety, 2012
- Validation of claims‐based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially‐insured populationPharmacoepidemiology and Drug Safety, 2010
- Use of disease risk scores in pharmacoepidemiologic studiesStatistical Methods in Medical Research, 2009
- The prognostic analogue of the propensity scoreBiometrika, 2008
- On the Estimation and Use of Propensity Scores in Case-Control and Case-Cohort StudiesAmerican Journal of Epidemiology, 2007
- Simultaneous assessment of short‐term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: An instrumental variable analysisArthritis & Rheumatism, 2006
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- STRATIFICATION BY A MULTIVARIATE CONFOUNDER SCOREAmerican Journal of Epidemiology, 1976